---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-005640"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2026-02-06T23:59:59+00:00"
generated_at: "2026-05-16T04:08:13.419893+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aspire Biopharma files Series A Convertible Preferred Stock with 80% discount conversion and price protection

## Summary
- Filed Certificate of Designation for 25,000 shares of Series A Convertible Preferred Stock on Feb 2, 2026.
- Conversion price at 80% of lowest closing price in 5 prior trading days; floor price at 20% of Nasdaq minimum price.
- Beneficial ownership conversion cap at 4.99% (can increase to 9.99% with 61-day notice).
- Holders get participation rights in 30% of future financings for 6 months; no voting rights.
- Shares rank senior to common; price protection adjusts conversion price on lower-priced issuances.

## SEC filing metadata
- accession: 0001493152-26-005640
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2026-02-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.03, 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315226005640/0001493152-26-005640-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315226005640/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-005640
- JSON: https://secwatch.observer/filing/0001493152-26-005640.json
- Plain text: https://secwatch.observer/filing/0001493152-26-005640.txt

## Key facts
- Governance Changes
  Aspire Biopharma Holdings, Inc.: Filed Certificate of Designation designating 25,000 shares of preferred stock as Series A Convertible Preferred Stock (effective 2026-02-02).
  - Change: charter amendment
  - Effective: 2026-02-02
  source text: Pursuant to the terms of the Securities Purchase Agreement, on February 2, 2026, the Company filed the Certificate of Designation with the Delaware Secretary of State designating, 25,000 shares of its authorized and unissued preferred stock as Series A Convertible Preferred Stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847345/000149315226005640/0001493152-26-005640-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.